Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer
Aim: To examine the relative cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer provided by Genetic Services of Western Australia. Methods: The relative cost-effectiveness was assessed using a decision analytic model. Results: The cost and outcomes of genetic testing was compared in first-degree relatives of known BRCA1/2 mutation-carriers who have a 50% risk ...
متن کاملGenetic counselling for familial breast and ovarian cancer in Ontario.
Advances in molecular medicine and increasing attention of the media to clinical developments in genetics have spurred the demand for genetic counselling services for several conditions, most notably for hereditary cancers. 2 Genetic counsellors in the Canadian province of Ontario serve a population of 11.7 million, of whom approximately 85% live in urban areas and 15% live in rural areas. The ...
متن کاملFamilial Breast and Ovarian Cancer
This text book is a timely publication and it gives a splendid overview of the genetics and management of familial breast and ovarian cancer. The book is edited by Professor Morrison and his colleagues and they have drawn together a national and an international list ofcontributors well respected in their fields. The book begins with a series of book chapters on molecular biology of these tumours.
متن کاملCost-effectiveness of a genetic test for breast cancer risk.
Genetic testing of seven single-nucleotide polymorphisms (7SNP) can improve estimates of risk of breast cancer relative to the Gail risk test alone, for the purpose of recommending MRI screening for women at high risk. A simulation of breast cancer and health care processes was used to conduct a virtual trial comparing the use of the 7SNP test with the Gail risk test to categorize patients by r...
متن کاملGenetic Testing for Breast and Ovarian Cancer
Genetic testing for breast and ovarian cancer has been publicly available since the mid-1990 discovery of two breast/ovarian cancer susceptibility genes named BRCA1 and BRCA2. Although many professionals say that genetic testing may be the best available preventative medicine breakthrough, controversy abounds over whether the medical benefits of BRCA1/2 mutation testing outweigh the psychologic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Genomics, Society and Policy
سال: 2005
ISSN: 1746-5354
DOI: 10.1186/1746-5354-1-2-67